LIVE MARKET TRACKER :   BSE SENSEX        |    NSE NIFTY    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Equity & Shares  :  Granules India gains on receiving USFDA approval for generic Methylergonovine tablets

Granules India gains on receiving USFDA approval for generic Methylergonovine tablets (17-May-2018)

Granules India is currently trading at Rs. 98.20, up by 1.45 points or 1.50% from its previous closing of Rs. 96.75 on the BSE.

The scrip opened at Rs. 97.90 and has touched a high and low of Rs. 98.20 and Rs. 97.65 respectively. So far 1,710 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 157.00 on 18-May-2017 and a 52 week low of Rs. 91.30 on 14-May-2018.

Last one week high and low of the scrip stood at Rs. 98.70 and Rs. 91.30 respectively. The current market cap of the company is Rs. 2,492.00 crore.

The promoters holding in the company stood at 44.94%, while Institutions and Non-Institutions held 17.55% and 37.51% respectively.

Granules India has received an approval from the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug Applications (ANDA) for Methylergonovine 0.2 mg Tablets. The ANDA was filed by Granules Pharmaceuticals Inc., a wholly owned subsidiary of Granules India. The approved ANDA is the bioequivalent to the reference listed drug product (RLD), Methergine 0.2 MG.

Methylergonovine is a semi-synthetic ergot alkaloid used for the prevention and control of postpartum haemorrhage.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).



Top News Today
Amara Raja Batteries reports 11% rise in Q4 net profit
(19-May-2018)

Amara Raja Batteries reports 11% rise in Q4 net profitAmara Raja Batteries has reported results for the fourth quarter and year ended March 31, 2018.The company has reported a rise of 10.70% in its net profit at Rs 109.80 crore for the quarter ended March......click on news to read complete article.

Inditrade Capital gets nod to acquire additional stake in JRG Fincorp
(19-May-2018)

Inditrade Capital gets nod to acquire additional stake in JRG FincorpInditrade Capital has received approval for acquisition of additional equity shares in its material subsidiary -- JRG Fincorp, of up to 10% of paid up capital, for an amount not exceeding Rs 24 crore within......click on news to read complete article.

Union Bank of India gets nod to raise funds up to Rs 7400 crore
(19-May-2018)

Union Bank of India gets nod to raise funds up to Rs 7400 croreUnion Bank of India has received approval from its board to raise capital not exceeding Rs 7400 crore by way of core equity capital or through bonds in 2018-19 (FY19). The meeting of the Board of Directors......click on news to read complete article.

International Stock News
US markets closed mostly lower; Dow ekes minor gain
(19-May-2018)

US markets closed mostly lower; Dow ekes minor gainThe US markets closed lower on Friday, with major indexes posting modest weekly declines as investors grappled with lingering uncertainty over trade negotiations between the US and China, as well as bond......click on news to read complete article.

US markets closed mostly lower; Dow ekes minor gain
(19-May-2018)

US markets closed mostly lower; Dow ekes minor gainThe US markets closed lower on Friday, with major indexes posting modest weekly declines as investors grappled with lingering uncertainty over trade negotiations between the US and China, as well as bond......click on news to read complete article.

US markets closed mostly lower; Dow ekes minor gain
(19-May-2018)

US markets closed mostly lower; Dow ekes minor gainThe US markets closed lower on Friday, with major indexes posting modest weekly declines as investors grappled with lingering uncertainty over trade negotiations between the US and China, as well as bond......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.